Evaluation of Aqueous Humor DEL-1 and IL-17 Levels in Diabetic Cataract Patients
Recruiting now · Not applicable
Conditions studied: Diabetic Group (n=30), Non-diabetic Group
In brief
By comparing DEL-1 and IL-17 levels in the aqueous humor of diabetic cataract patients with the aqueous humor of non-diabetic patients, we aim to understand the biochemical effects of diabetes-related inflammatory processes in the eye.
Key facts
- Study ID
- NCT06995131
- Run by
- Uşak University
- People needed
- 60
- Starts
- 2025-05-01
- Expected to finish
- 2025-08-15
- Last updated by the study team
- 2025-06-05
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Cataract diagnosed and surgery planned
- Patients without any other ocular pathology other than cataract.
- Type 2 DM for at least 5 years in the diabetic group
You may not qualify if…
- Patients with previous intraocular surgery
- Those with inflammatory eye diseases (e.g. uveitis)
- Those with autoimmune diseases or systemic inflammatory diseases
- Those receiving local or systemic steroid therapy
- Those with severe systemic disease (e.g. advanced renal failure, malignancy)
Where it is running
- Uşak Training and Research Hospital — Uşak, Uşak, Turkey (Türkiye) (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.